H Stewart Parker is Director of IMPEL PHARMACEUTICALS INC. Currently has a direct ownership of 17,756 shares of IMPL, which is worth approximately $355. The most recent transaction as insider was on Apr 27, 2021, when has been sold 2,124 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.8K
0% 3M change
0% 12M change
Total Value Held $355

H STEWART PARKER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 27 2021
SELL
Other acquisition or disposition
-
2,124 Reduced 10.68%
17,756 Common Stock
Apr 27 2021
BUY
Conversion of derivative security
$272,038 $13.5 p/Share
20,151 Added 52.78%
18,027 Common Stock

Also insider at

SGMO
SANGAMO THERAPEUTICS, INC Healthcare
CDXS
CODEXIS, INC. Healthcare
HSP

H Stewart Parker

Director
Brisbane, CA

Track Institutional and Insider Activities on IMPL

Follow IMPEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMPL shares.

Notify only if

Insider Trading

Get notified when an Impel Pharmaceuticals Inc insider buys or sells IMPL shares.

Notify only if

News

Receive news related to IMPEL PHARMACEUTICALS INC

Track Activities on IMPL